联合测定空腹血糖和糖化血清蛋白在糖尿病检测中的临床疗效分析

Analysis of Clinical Efficacy of Combined Determination of Fasting Blood Glucose and Glycosylated Serum Protein in Diabetes Detection

目的评价空腹血糖、糖化血清蛋白联合检测对糖尿病的诊断价值。方法选择2020年1月—2021年1月期间该院收治的50例糖尿病患者,设为研究组;选择同期进行体检的50名健康者,设为对照组。两组患者均采取空腹血糖+糖化血清蛋白联合检测并组间对比测定结果。为研究组患者采取降糖治疗,对比治疗前后患者的空腹血糖、糖化血清蛋白水平,以衡量治疗效果。结果研究组的糖化血清蛋白、空腹血糖测定结果均高于对照组,差异有统计学意义(P<0.05)。研究组治疗前的糖化血清蛋白、空腹血糖测定结果均高于治疗后,差异有统计学意义(P<0.05)。结论空腹血糖、糖化血清蛋白联合检测不仅可以用于诊断患者是否患有糖尿病,还可以用于评估患者的降糖治疗效果,其临床应用价值十分显著。

Objective To evaluate the diagnostic value of combined detection of fasting blood glucose and glycosylated serum protein for diabetes.Methods Fifty patients with diabetes who were admitted from January 2020 to January 2021 were selected as the study group;choose 50 healthy people who hare undergone physical examination during the same period and set them as the control group.Both groups of patients were taken fasting blood glucose+glycosylated serum protein combined detection and the results were compared between the groups.The patients in the study group were treated with hypoglycemic therapy,and the fasting blood glucose and glycosylated serum protein levels of the patients before and after the treatment were compared to measure the treatment effect.Results The results of glycated serum protein and fasting blood glucose of the study group were higher than those of the control group,the difference was statistically significant(P<0.05).The results of glycated serum protein and fasting blood glucose before treatment in the study group were higher than those after treatment,and the difference was statistically significant(P<0.05).Conclusion The combined detection of fasting blood glucose and glycosylated serum protein can be used not only to diagnose whether a patient has diabetes,but also to assess the effect of hypoglycemic treatment in patients,and its clinical application value is very significant.